Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedA new revision label v3.5.4 appears, replacing the previous v3.5.3 in the record history. This indicates a published update to the page metadata without changing the underlying study details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedUpdates the ClinicalTrials.gov page revision/version indicator from v3.5.2 to v3.5.3, with no change to the underlying study record content.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.0 was added and revision v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision changed from v3.4.2 to v3.4.3 in the Record History. No study content or user actions are affected.SummaryDifference0.1%

- Check98 days agoChange DetectedA new site revision entry 'Revision: v3.4.2' was added to the history, and the notices for government funding lapse and the previous 'Revision: v3.4.1' were removed from deletions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.